XENO
Healthcare BiotechnologyXeno Transplants Corporation
$0.00
+0.00 +0.00% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 3:20 PM ET | 0.00 |
Key Stats
Market Cap
64,582
Avg Volume
1
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%
Valuation
P/B Ratio
0.10
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Liquidity & Leverage
Current Ratio
0.15
Quick Ratio
0.13
Debt / Equity
15.09
Total Cash
261
Total Debt
502,231
About
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.